Key players in the Specialty Enzymes Market
by Mit K. SEOThe specialty
enzymes market was valued at USD 4.4 billion in 2019 and is projected
to reach USD 6.6 billion by 2025, recording a CAGR of 6.9% during the forecast
period. The demand for enzymes is increasing significantly, as it is being used
across various specialty applications and as a substitute for chemical
catalysts.
Key players in this market include BASF (Germany), Novozymes
(Denmark), Roche Holding (Switzerland), DuPont (US), Codexis (US), Dyadic
International (US), Advanced Enzymes (India), Amano Enzymes (Japan), Sanofi
(France), Biocatalysts (UK), Enzyme Supplies (UK), BBI Solutions (UK), Specialty
Enzymes & Probiotics (US), Amicogen (South Korea), Antozyme Biotech
(India), Enzyme Development Corporation (US), Nagase & Co. Ltd. (Japan),
Sekisui Diagnostics (US), Merck (Germany), and Biovet (Bulgaria).
Download PDF
brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21682828
Novozymes (Denmark)
is a major bio-innovation company providing biological solutions, which
involves the application of enzymes and microbes. The company offers various
products, which cater to industries, such as household care, food &
beverage, bioenergy, agriculture & feed, and technical & pharma.
Novozymes has been introducing new products for making its product portfolio
diverse. In addition, the company is focused on expanding its global presence
to prosper in the global enzymes market. Currently, it has been catering to all
the major regions, such as North America, Latin America, Asia Pacific, Europe,
the Middle East, and Africa. It focuses on innovation activities to identify
new opportunities in the specialty enzymes market. For instance, in May 2019,
Novozymes became the first multinational company to partner with Alibaba’s 1688
platform in industrial biotechnology in China. This would boost the usage of
enzymes among small & medium sized enterprises in China.
BASF (Germany)
is a global chemical manufacturing company and specializes in catering to
segments, such as chemicals, performance products, functional materials &
solutions, agricultural solutions, and others. Along with this, the company has
been investing mainly in biotechnology and large-scale production of enzymes.
The strategies that are being adopted by BASF to be a market leader in the
specialty enzymes market are collaborations and expansions. In addition, to
make its product portfolio diverse, the company has been focusing on launching
new products and expansions. BASF has three global research divisions, which
are operated from Europe, Asia Pacific, and North America. For instance, BASF
had set up its enzyme-based production plant for biocatalyzed acrylamide in
Nanjing, China. This was the first biocatalyzed acrylamide (BioACM) plant in
Asia Pacific. This would cater the demand for specialty enzymes in the Asia
Pacific region.
Contact:
Mr.
Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Sponsor Ads
Created on Oct 5th 2020 06:48. Viewed 233 times.